Education
About Us
Working with TipRanks
Follow Us
VITA 34 AG (DE:V3V)
XETRA:V3V
V3V Stock Chart & Stats
€6.10
€0.00(0.00%)
At close: 4:00 PM EST
€6.10
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€3.70 - €7.65
Previous CloseN/A
Volume271.00
Average Volume (3M)1.65K
Market Cap
€106.33M
Enterprise Value€85.60M
Total Cash (Recent Filing)€13.05M
Total Debt (Recent Filing)€19.35M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding17,640,104
10 Day Avg. Volume2,079
30 Day Avg. Volume1,645
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)5.08
Price to Sales (P/S)0.87
P/FCF Ratio13.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
V3V FAQ
What was VITA 34 AG’s price range in the past 12 months?
VITA 34 AG lowest stock price was €3.70 and its highest was €7.65 in the past 12 months.
What is VITA 34 AG’s market cap?
VITA 34 AG’s market cap is €106.33M.
When is VITA 34 AG’s upcoming earnings report date?
VITA 34 AG’s upcoming earnings report date is Mar 31, 2026 which is in 96 days.
How were VITA 34 AG’s earnings last quarter?
VITA 34 AG released its earnings results on Nov 21, 2025. The company reported €0.068 earnings per share for the quarter, beating the consensus estimate of N/A by €0.068.
Is VITA 34 AG overvalued?
According to Wall Street analysts VITA 34 AG’s price is currently Overvalued.
Does VITA 34 AG pay dividends?
VITA 34 AG pays a Annually dividend of €0.16 which represents an annual dividend yield of N/A. See more information on VITA 34 AG dividends here
What is VITA 34 AG’s EPS estimate?
VITA 34 AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VITA 34 AG have?
VITA 34 AG has 17,640,104 shares outstanding.
What happened to VITA 34 AG’s price movement after its last earnings report?
VITA 34 AG reported an EPS of €0.068 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of VITA 34 AG?
Currently, no hedge funds are holding shares in DE:V3V
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
VITA 34 Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.44%
12-Months-Change
Fundamentals
Return on Equity
-50.39%
Trailing 12-Months
Asset Growth
-0.15%
Trailing 12-Months
Company Description
VITA 34 AG
VITA 34 (V3V) is a leading company in the field of stem cell storage and regenerative medicine. Based in Germany, VITA 34 specializes in the collection, processing, and storage of umbilical cord blood stem cells, offering vital services to families looking to preserve the potential for future medical treatments. The company operates within the healthcare and biotechnology sectors, focusing on the development of therapies that leverage the unique properties of stem cells for various medical applications.
Technical Analysis
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
HAEMATO AG
―
Gesundheitswelt Chiemgau AG
―
MPH Health Care AG
―